(Eureka, CA. – April 7, 2020) – St Joseph Hospital in Eureka announced today its participation
in two national clinical trials of anti-viral drug Remdesivir for the
treatment of moderate and severe COVID-19. The experimental drug has shown
promise in the treatment of COVID-19.
The clinical trial has been offered at Providence St. Joseph Health hospitals
in Portland, OR and Washington state. Providence St. Joseph Health (PSJH),
the parent organization of St. Joseph Health, Humboldt County, has had
a highly coordinated response to COVID-19 which includes implementation
of clinical trials at several hospitals within the 51-hospital system.
St Joseph Hospital Eureka is the only hospital within St Joseph Health,
Northern California to open as a site for these clinical trials. The hospital
was chosen due to an established relationship with the principal investigator
of the trial and was proactive in seeking accelerated approval for the
trials in Humboldt.
“This is an important opportunity for future patients who present
with COVID – 19 at St. Joseph Hospital and meet certain criteria,
to have access to Remdesivir, a promising investigational drug,”
said Dr. Roberta Luskin-Hawk, Chief Executive, St. Joseph Health, Humboldt County.
Luskin-Hawk, an infectious disease physician with extensive clinical research
experience including working with National Institute of Allergy and Infectious
Diseases Director Dr. Anthony Fauci during the AIDS epidemic, continued,
“The main goal of the trial is to evaluate the effectiveness and
safety of the medication. We are incredibly fortunate to have the local
expertise in Humboldt to facilitate the trials. The undertaking has required
a great deal of work and planning, and we are thrilled to be part of this
St. Joseph Health Medical Group physician Dr. Igor Abolnik, a local infectious
disease specialist will serve as the trial’s principal investigator.
Kate Cruz, area manager, pharmacy services at St. Joseph Hospital will
be helping coordinate the clinical trial.
The intravenous drug produced by biopharmaceutical company Gilead Sciences
Inc. of Foster City, CA, was used in the global fight against the Ebola
outbreak. Gilead Sciences is in two phase-three clinical studies to evaluate
Remdesivir in adults diagnosed with COVID-19. Approval will come after
phase three if the drug is found to be safe and effective. The U.S. Food
and Drug Administration put the drug in rapid review. The study will use
about 1,000 patients across the country and should be completed by May.
About St. Joseph Health, Humboldt County
St. Joseph Health, Humboldt County (SJHS-HC) is committed to meeting the
highest standards in health care delivery while ministering to the needs
of the whole person – body, mind and spirit. This commitment to
the people of the North Coast is expressed in the St. Joseph Health System's
five core values – Compassion, Dignity, Excellence, Justice and
Integrity. St. Joseph Health, Humboldt County offers a comprehensive network
of specialty care and services including a Level III Trauma Center, Level
II Neonatal Intensive Care Unit, and a Cancer Center Accredited by the
Commission on Cancer. The health care ministry of the Sisters of St. Joseph
of Orange began in Humboldt County during the flu epidemic of 1918. The
Sisters opened the first St. Joseph Hospital in Eureka in 1920 and committed
to continually improving the health and quality of life of the people
served. This commitment continues today and has been further defined by
the vision of St. Joseph Health –Health for a Better World.